<b>Methods:</b> We analyzed the Mayo Clinic PSMA PET Prostate Cancer Registry to identify patients with rDP on PSMA PET/CT despite undetectable PSA levels. This evidence concerns the gene FOLH1 and Familial prostate cancer.